Question 1

The most effective component to treat a patient with von Willebrand's disease is:

Accepted Answer

A) fresh frozen plasma. 
B) red blood cells. 
C) platelets. 
D) cryoprecipitated AHF. 
A) fresh frozen plasma. 
B) red blood cells. 
C) platelets. 
D) cryoprecipitated AHF.

Question 2

Match the component with the indications for use.Each can be used more than once.
-Avoid graft-versus-host disease

Accepted Answer

A) Cryoprecipitated AHF 
B) Fresh frozen plasma 
C) Red blood cells 
D) Platelets 
E) Leuko-reduced blood components
F)Washed red blood cells
G)Albumin/plasma protein fraction
H)Factor concentrates
I)Plasma,cryoprecipitate reduced
J)Irradiated blood products 
A) Cryoprecipitated AHF 
B) Fresh frozen plasma 
C) Red blood cells 
D) Platelets 
E) Leuko-reduced blood components
F)Washed red blood cells
G)Albumin/plasma protein fraction
H)Factor concentrates
I)Plasma,cryoprecipitate reduced
J)Irradiated blood products

Question 3

ABO-matched organ transplants are critical in all the following except:

Accepted Answer

A) bone marrow. 
B) kidney. 
C) heart. 
D) liver. 
A) bone marrow. 
B) kidney. 
C) heart. 
D) liver.

Question 4

Match the component with the indications for use.Each can be used more than once.
-Deficiency of factor XIII and von Willebrand's factor

Accepted Answer

A) Cryoprecipitated AHF 
B) Fresh frozen plasma 
C) Red blood cells 
D) Platelets 
E) Leuko-reduced blood components
F)Washed red blood cells
G)Albumin/plasma protein fraction
H)Factor concentrates
I)Plasma,cryoprecipitate reduced
J)Irradiated blood products 
A) Cryoprecipitated AHF 
B) Fresh frozen plasma 
C) Red blood cells 
D) Platelets 
E) Leuko-reduced blood components
F)Washed red blood cells
G)Albumin/plasma protein fraction
H)Factor concentrates
I)Plasma,cryoprecipitate reduced
J)Irradiated blood products

Question 5

CMV-safe blood is required for which category of patients?

Accepted Answer

A) Sickle cell 
B) Neonatal 
C) Cardiac 
D) Trauma 
A) Sickle cell 
B) Neonatal 
C) Cardiac 
D) Trauma

The most effective component to treat a patient with von Willebrand's disease is:

Match the component with the indications for use.Each can be used more than once. -Avoid graft-versus-host disease

ABO-matched organ transplants are critical in all the following except:

Match the component with the indications for use.Each can be used more than once. -Deficiency of factor XIII and von Willebrand's factor

CMV-safe blood is required for which category of patients?

Immunology: Basic Principles and Applications in the Blood Bank

Blood Banking Reagents: Overview and Applications

Genetic Principles in Blood Banking

Abo and H Blood Group Systems and Secretor Status

Rh Blood Group System

Other Blood Group Systems

Antibody Detection and Identification

Compatibility Testing

Blood Bank Automation for Transfusion Services

Adverse Complications of Transfusions

Hemolytic Disease of the Fetus and Newborn

Donor Selection and Phlebotomy

Testing of Donor Blood

Blood Component Preparation and Therapy

Quality Assurance and Regulation of the Blood Industry and Safety Issues in the Blood Bank

Filters

Exam 15: Transfusion Therapy in Selected Patients

The most effective component to treat a patient with von Willebrand's disease is:

Match the component with the indications for use.Each can be used more than once. -Avoid graft-versus-host disease

ABO-matched organ transplants are critical in all the following except:

Match the component with the indications for use.Each can be used more than once. -Deficiency of factor XIII and von Willebrand's factor

CMV-safe blood is required for which category of patients?

Immunology: Basic Principles and Applications in the Blood Bank

Blood Banking Reagents: Overview and Applications

Genetic Principles in Blood Banking

Abo and H Blood Group Systems and Secretor Status

Rh Blood Group System

Other Blood Group Systems

Antibody Detection and Identification

Compatibility Testing

Blood Bank Automation for Transfusion Services

Adverse Complications of Transfusions

Hemolytic Disease of the Fetus and Newborn

Donor Selection and Phlebotomy

Testing of Donor Blood

Blood Component Preparation and Therapy

Quality Assurance and Regulation of the Blood Industry and Safety Issues in the Blood Bank

Filters